openPR Logo
Press release

Hospital Infection Therapeutics Market Size, Share, Overview, Key Players and Opportunities 2022-2027

10-06-2022 08:01 AM CET | Health & Medicine

Press release from: IMARC Group

Hospital Infection Therapeutics Market Size, Share, Overview,

According to IMARC Group's latest report, titled "Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global hospital infection therapeutics market reached a value of around US$ 11 Billion in 2021. Looking forward, IMARC Group expects the global hospital infection therapeutics market to grow at a CAGR of 2.4% during 2022-2027.

Hospital infection therapeutics refers to drugs or medications used to treat diseases or infections. They can be acquired from viral, bacterial and fungal pathogens present in hospitals, nursing homes, rehabilitation centers, outpatient clinics, and other treatment centers. Therapeutics, such as antibacterial, antiviral, antifungal, and infection-based drugs, are used to prevent hospital-acquired infections (HAIs) like urinary tract infections (UTI), pneumonia, surgical site infection, and bloodstream infections (BSI).

Request for a PDF sample of this report: https://www.imarcgroup.com/hospital-infection-therapeutics-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Hospital Infection Therapeutics Market Trends:

The global hospital infection therapeutics market is primarily driven by the rising prevalence of chronic diseases that have increased hospital admissions and cases of HAIs. The growing geriatric population and rising healthcare expenditure are also escalating the demand for these therapeutics. Furthermore, there has been a development of advanced therapies, drugs, vaccines and coverings that can be used for the treatment of infections with specific symptoms. Moreover, extensive investment in research and development (R&D) activities to develop new HAI drugs, such as Zerbaxa by Merck & Co., for the treatment of ventilator-associated bacterial pneumonia (VABP), are expected to influence the market growth in the near future.

Hospital Infection Therapeutics Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global hospital infection therapeutics market has also been examined along with the profiles of the key players.

Some of these key players include:
Allergan Plc (AbbVie Inc.)
AstraZeneca Plc
Bayer Aktiengesellschaft
Bristol-Myers Squibb Company
Hoffmann-La Roche AG (Roche Holding AG)
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Pfizer Inc.
Sanofi S.A.

Key Market Segmentation:

The report has segmented the hospital infection therapeutics market based on drug type, indication, and region.

Breakup by Drug Type:
Anti-bacterial Drugs
Anti-fungal Drugs
Anti-viral Drugs
Others

Breakup by Indication:
Blood Stream Infections
Urinary Tract Infections
Surgical Site Infections
Pneumonia
Others

Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2393&flag=C

Key highlights of the report:

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Apheresis Equipment Market: https://bit.ly/3M93n4m

RNA Interference Drug Delivery Market: https://bit.ly/3ROPjyp

Multiple Sclerosis Therapies Market: https://bit.ly/3rzqFXH

Portable Medical Ventilators Market: https://bit.ly/3EgRNCq

Nucleic Acid Labelling Market: https://bit.ly/3V4i4Kb

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hospital Infection Therapeutics Market Size, Share, Overview, Key Players and Opportunities 2022-2027 here

News-ID: 2758616 • Views:

More Releases from IMARC Group

Nanofibers Market Size, Share, and Report 2024-2032
Nanofibers Market Size, Share, and Report 2024-2032
According to IMARC Group latest report titled "Nanofibers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032", offers a comprehensive analysis of the industry, which comprises insights on nanofibers market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global nanofibers market size reached US$ 1,591.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 9,948.5 Million by
Oxygen Concentrator Manufacturing Plant Report 2024: Business Plan, Capital Investments and Expenses
Oxygen Concentrator Manufacturing Plant Report 2024: Business Plan, Capital Inve …
IMARC Group's report, titled "Oxygen Concentrator Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue," provides a complete roadmap for setting up an oxygen concentrator manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition
Sweet Almond Oil Processing Plant Cost 2024: Industry Trends, Machinery and Raw Materials
Sweet Almond Oil Processing Plant Cost 2024: Industry Trends, Machinery and Raw …
IMARC Group's report, titled "Sweet Almond Oil Processing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue," provides a complete roadmap for setting up a sweet almond oil processing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and
Gummed Paper Tape Manufacturing Plant Project Report 2024: Industry Trends, Setup Cost and Investment Opportunities
Gummed Paper Tape Manufacturing Plant Project Report 2024: Industry Trends, Setu …
IMARC Group's report titled "Gummed Paper Tape Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a gummed paper tape manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more.

All 5 Releases


More Releases for Infection

Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026. The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,
Human papillomavirus infection Treatment
Human Papillomavirus Infection Forecast 2019-2024 Drugs for Human Papillomavirus Infections Market Insights 2019, Global and Chinese Scenario is a professional and in depth study on the current state of the global Drugs for Human Papillomavirus Infections industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drugs for Human Papillomavirus Infections manufacturers and is a valuable source of guidance and direction for
Infection Prevention and Control
Infection control products and accessories aids in the prevention and control of hospital associated & other healthcare infections. These products range from disinfectants to sterilization equipment used in the healthcare settings. Infections needs to be controlled while injecting the drugs, during the surgery and hospital stay of a patient. In addition, infection control and preventive measures aid to avoid the most common hospital infections among the healthcare staff. Get Free 10
Yeast Infection Market 2018 Global Industry Analysis By Site of infection (Vagin …
This Report Expects To Examine The Developments Of A Global Yeast Infection Market Including Its Market Improvement, Development Position Etc. Global Yeast Infection Market Research Report Will Help To Take Informed Decisions, Understand Opportunities, Plan Effective Business Strategies, Plan New Projects, Analyze Drivers And Restraints And Give Vision On The Forecast. Report Is A Specialist And Broad Research Report On The Major Regional Market Conditions, Concentrating On The United States, China,
Gram-Negative Bacterial Infection Market - Infection-type Segmentation 2017 - 20 …
Global Gram-Negative Bacterial Infection Market: Snapshot Worldwide, antimicrobial resistance is a soaring concern for a range of diseases, especially for enteric fever, respiratory tract infections, and various infections related with gram-negative bacilli (GNB). An upsurge in antibiotic resistance is mainly due to indiscriminate and inappropriate use of antibiotics and a marked decline in the development of efficacious antimicrobial agents. According to the Centers for Disease Control and Prevention (CDC), the
Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteri …
"The Report Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Infectious enteric diseases are usually caused by a variety of bacteria, viruses and parasites when they enter